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Purpose: To investigate the amount of single-stranded DNA breaks in circulating leukocytes of primary open-angle
glaucoma (POAG) patients.
Methods: A comparative quantification of DNA breaks was performed in circulating leukocytes of POAG patients and
healthy  controls.  The  following  groups  of  subjects  were  compared:  (1)  POAG  patients  having  primary  vascular
dysregulation (PVD), (2) POAG patients without PVD, (3) healthy controls with PVD, and (4) healthy controls without
PVD. The damage to DNA resulting in single-stranded breaks was assessed by means of the alkaline comet assay in which
the damaged DNA migrates out of the nucleus forming a tail, which can be quantified using image analysis. Damage was
quantified as the comet tail moment, which represents the extent of DNA damage in individual cells.
Results: Leukocytes of POAG patients exerted a significantly higher amount of comet tails, which are indicative of DNA
damage, in comparison to control leukocytes (p<0.001). DNA breaks occurred particularly in the subgroup of POAG
patients with PVD in comparison to glaucoma patients without PVD (p=0.002). In the control group, there was no
significant difference between controls with PVD and controls without PVD (p=0.86).
Conclusions: POAG patients with PVD have a significantly higher rate of DNA breaks than both POAG patients without
PVD and healthy controls with and without PVD.
Approximately 0.000165% of the DNA of the human’s
genome is damaged at any given time [1]. DNA damage can
occur as double-strand breaks, which result from two damages
in opposite strands of the DNA helix, or as single–strand
breaks, which result when only one of the two strands of a
double helix has a defect [2]. The amount of DNA breaks
depends on different factors such as cell type, the age of the
cell,  and  the  extracellular  environment  [3-5].  Fortunately,
DNA damage can be repaired by various mechanisms [6]. In
the  physiologic  state,  generation  of  DNA  breaks  and
subsequent DNA repair is more or less balanced. In other
words, there is a "steady-state" [7]. However, if the damage
induced is greater than the repair capacity, the amount of DNA
breaks  increases,  and  it  may  finally  contribute  to  the
development of disease.
In primary open-angle glaucoma (POAG), an increased
number  of  DNA  breaks  has  been  described  both  in  the
trabecular  meshwork  [8,9]  and  and  systemically  in  the
circulating leukocytes [10]. The purpose of this investigation
is  to  confirm  increased  DNA  breaks  in  the  circulating
leukocytes of POAG patients and to test whether there is an
association between primary vascular dysregulation (PVD)
and DNA breaks.
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METHODS
Subjects:  Patients  with  primary  open-angle  glaucoma
(POAG) were recruited from the University Eye Clinic in
Basel,  Switzerland  between  January  2006  and  September
2007. Healthy volunteers that were age and sex matched to
POAG  patients  were  recruited  after  a  notification  in  the
University  Clinic  informing  potential  volunteers  of  the
opportunity  to  participate  in  a  scientific  research  project.
Ethical approval was obtained from the local medical ethics
committee, and written informed consent was received from
all  subjects  before  entry  into  the  study.  The  study  was
designed  and  conducted  in  accordance  with  the  tenets  of
Declaration of Helsinki.
Patients with POAG had to meet the following inclusion
criteria: (1) treated intraocular (IOP) less than 23 mmHg on
multiple  measurements,  (2)  progressive  changes  in  either
visual field in at least three successive perimetric tests, (3)
optic nerve cupping, (4) open angles on gonioscopy, and (5)
the absence of alternative causes of optic neuropathy (e.g.,
other types of glaucoma). Both POAG patients and healthy
subjects with any of the following criteria were excluded: a
history  of  other  ocular  or  systemic  disease  (e.g.,  diabetes
mellitus), smoking, drug or alcohol abuse, trauma, infection,
or inflammation. PVD was defined as being present if it was
detected in both the patient history as well as by nailfold
capillaromicroscopy. PVD was defined as being absent if the
patient  history  for  PVD  was  negative  and  the  results  of
nailfold capillaromicroscopy were negative. Cases in which
patient  history  and  nailfold  capillaromicroscopy  were
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1584contradictory were excluded from the study. The following
groups of subjects were compared: (1) POAG patients having
PVD, (2) POAG patients without PVD, (3) healthy controls
with  PVD,  and  (4)  healthy  controls  without  PVD.
Demographic data of the different groups of subjects are given
in Table 1.
Isolation  of  leukocytes:  Blood  samples  (20  ml)  anti-
coagulated with heparin were obtained by venipuncture from
glaucoma patients and controls (PVD and non-PVD in both
groups).  The  leukocytes  were  isolated  using  Ficoll-
Histopaque  gradients  ((Histopaque  1077;  Sigma-Aldrich,
Switzerland)) as previously described [10]. The leukocyte
bands were removed from the interface between plasma and
the histopaque layers of each tube and collected into one 50
ml tube. The total volume was brought to 50 ml with cold
Dulbecco’s  Modified  Eagle  Medium  (DMEM;  Gibco,
Invitrogen, Basel,
Switzerland).  The  cell  suspension  was  washed  three
times  with  DMEM,  and  the  total  number  of  cells  was
determined.  Cells  were  finally  suspended  in  phosphate
buffered saline (PBS) and aliquoted into Eppendorf tubes at
107 cells/tube. After centrifugation, cell pellets were stored at
−80 °C.
Single cell gel electrophoresis (Comet assay): This simple,
sensitive technique permits the detection of single-stranded
DNA  damage  in  single  cells  when  performed  in  alkaline
conditions. This method has previously been described in
detail  in  the  literature  [11].  The  cells  under  study  are
embedded in agarose on a slide and subjected to lysis followed
by  electrophoresis  under  specific  conditions.  During
electrophoresis,  the  damaged  and  fragmented  negatively
charged DNA migrates away from the nucleus toward the
anode. The amount of migrated DNA is a measure of the
extent of DNA damage. To detect DNA, the slides are stained
with cyber green and examined by fluorescence microscopy
equipped with a personal computer based analysis system
(Kinetic Imaging; Nikon, Zürich, Switzerland), which enables
quantification of DNA damage. Cells containing damaged
DNA have the appearance of a comet with a bright head and
tail. In contrast, undamaged DNA appears as an intact nucleus
with no tail (Figure 1).
Quantification  of  DNA  breaks:  It  is  recommended  by
manufacturers that 50 cells on each slide be chosen at random
for  quantification  of  DNA  damage  using  the  computer
software. The tail moment is defined as the product of the tail
length  and  the  fraction  of  total  DNA  in  the  tail  (Tail
moment=tail length x % of DNA in the tail). This is calculated
automatically by the computer software system as an average
for the 50 cells selected for measurement.
In addition, a function known as the olive tail moment is
automatically obtained by the computer software system for
each cell analyzed. This parameter essentially represents the
product of the percentage of total DNA in the tail and the
distance between the centers of the mass of head and tail
regions [Olive moment=(tail mean-head mean) x % of DNA
Figure 1. Photographs of cells analyzed by comet assay analysis. This
figure shows photographs taken from the comet assay analysis. Each
spot represents the DNA of an individual cell. The “dark/white”
round spot represents the intact DNA. Intact DNA is a large molecule
that does not migrate much in the electrophoretic field. The less dark
“comet shaped” area adjacent to the nucleus represents DNA breaks
that are small enough to move in the gel. The arrow in A points
toward a virtually intact cell whereas the arrow in B points toward a
cell with a large “comet”, which is indicative of a large amount of
DNA breaks.
TABLE 1. DEMOGRAPHIC DATA OF THE STUDY GROUPS.
Control Glaucoma
p value PVD- PVD+ PVD- PVD+
N 8 6 6 8
Age 57 (14) 46 (17) 46 (14) 46 (14) n.s. (*)
Mean IOP 13 (2.4) 15 (2.7) 13 (1.5) 12 (2.0) n.s. (*)
Male 37.5% 50% 50% 37.5% n.s. (**)
Female 62.5% 50% 50% 62.5% n.s. (**)
Age and IOP are expressed as mean (SD). An asterisk indicates that the p value was obtained by one way ANOVA, and a double
asterisk  indicates that the p value was obtained by Fisher’s exact test. PVD+: with a primary vascular dysregulation; PVD-:
without a primary vascular dysregulation.
Molecular Vision 2008; 14:1584-1588 <http://www.molvis.org/molvis/v14/a188> © 2008 Molecular Vision
1585in the tail]. All comets were quantified by three independent
observers.
Statistical analysis: The parameters used for the statistical
evaluation were the tail moment and olive tail moment. As
both parameters were zero-inflated (had many zeros), their
distribution  was  heavy-tailed.  The  assumptions  for  usual
regression modeling were therefore violated. To overcome
this problem, the fraction of non-zero values compared to the
total number of observations was counted for each subject.
These fractions were approximately normally distributed. To
detect the effect of the study group, PVD, and the observer on
tail moment and olive moment, a linear mixed-effect model
was performed. “Study group,” “observer,” and “PVD” are
fixed effects of the model; “subject” was treated as a random
effect. All possible interactions between the three main effects
were included in the model.
The model also allowed for heteroscedasticity (unequal
variances)  in  the  factor  levels.  Additionally,  the  standard
deviation  between  observers  was  calculated,  treating
“observer”  as  a  random  effect.  All  evaluations  were
performed using the statistical package R version 2.4.0 (SPSS
2006, Basel, Switzerland).
RESULTS
Tail moment: Table 2 depicts the quantifications of DNA
breaks (in the tail moment and olive moment) in controls and
glaucoma  patients.  The  data  presents  the  mean,  median,
minimum, maximum, and standard deviation of fractions of
non-zero values for each individual.
POAG leukocytes exerted a significantly higher number
of comet tails indicative of DNA damage in comparison to
control  leukocytes  (p<0.001).  There  was  a  significant
interaction between “PVD” and “study group” (p<0.001) as
shown in Figure 2. This means that within the control group,
there  was  no  difference  between  the  PVD  and  non-PVD
subgroups (p=0.86). In the glaucoma group, however, there
was a clear significant difference between PVD and non-PVD
subgroups (p=0.002). The interactions of observers with other
effects (study group and PVD) were not significant and were
removed  from  the  model.  The  inter-observer  standard
deviation was estimated as 12%.
Olive moment: There were no significant interactions between
any of the three factors. Therefore, the model was reduced to
the  three  main  effects.  There  were  significant  effects  for
“study  group”  (p<0.001)  and  “PVD”  (p=0.046),  and  no
significant effect for “observer” (p=0.12). The inter-observer
standard deviation was estimated as 9%.
DISCUSSION
In this study we quantified single-stranded (ss) DNA breaks
in circulating leukocytes of two subgroups of POAG patients,
namely those with PVD and those without PVD. These results
were compared to healthy subjects with and without PVD.
Based on the results of the comet assay, we conclude that
POAG patients with PVD have a significantly higher rate of
DNA  breaks  than  both  POAG  patients  without  PVD  and
healthy controls with and without PVD.
Single-stranded DNA breaks can result from a variety of
factors  including  UV  light  [12],  X-rays  [13],  ionizing
radiation  [14],  toxins  [15],  chemicals  [16],  and  reactive
oxygen  species  (oxidative  stress),  all  of  which  result  in
byproducts of normal metabolic processes [17]. The most
likely  reason  for  a  higher  rate  of  DNA  breaks  in  POAG
patients, especially in those patients having PVD, is increased
oxidative stress. Oxidative stress occurs under a condition of
high energy consumption, light exposure, or age-depending
decline of coping capacity to deal with free radicals [18]. In
glaucoma, an additional major factor is most likely a repeated
mild reperfusion injury [19].
As a part of the systemic dysregulation, there is also some
dysregulation  of  the  ocular  perfusion  (disturbed
autoregulation)  [20,21].  As  a  consequence  of  disturbed
autoregulation, fluctuation of IOP or blood pressure leads to
a fluctuation of ocular perfusion and thereby to an unstable
oxygen supply [22]. The resulting repeated mild reperfusion
increases oxidative stress. Indeed, several findings indicate an
increase in oxidative stress in glaucoma patients [8,9,23-28].
Among  the  controls,  no  significant  differences  were
observed for single-stranded DNA breaks between the PVD
and  non-PVD  groups.  Taken  together,  our  findings  may
indicate  that  PVD  in  glaucoma  patients  contributes  to
oxidative stress. It may, however, also indicate that PVD
subjects  have  a  less  efficient  antioxidant  defense  system.
Preliminary studies show that glaucoma patients display a
significant depletion of total antioxidant potential in their
aqueous  humor  [24],  a  decrease  in  plasmatic  glutathione
levels  [29],  and  an  increase  in  serum  antibodies  against
Figure 2. Comet assay analysis of the tail moment in glaucoma
patients and controls. PVD+: with a primary vascular dysregulation;
PVD-: without a primary vascular dysregulation.
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1586glutathione-S-transferase, which indicate reduced antioxidant
defense in these patients [30]. However, the increase in DNA
breaks in glaucoma patients with PVD may also reflect a
weaker  DNA  repair  capacity.  Indeed,  a  different  gene
expression in the lymphocytes of glaucoma patients with PVD
has been described both at the mRNA and at the protein level
[31-34].
In  summary,  POAG  patients  with  PVD  have  a
significantly higher rate of DNA breaks than both POAG
patients without PVD and healthy controls with and without
PVD.  Further  investigations  on  the  role  of  systemic
antioxidant status and DNA repair capacity in these patients
may have implications for understanding the pathophysiology
of glaucoma.
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